Page last updated: 2024-08-21

cyclopentane and Leukemia, Promyelocytic, Acute

cyclopentane has been researched along with Leukemia, Promyelocytic, Acute in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Andricopulo, AD; Barroso de Oliveira, AS; Coelho, F; Costa-Lotufo, LV; da Silva, JCL; Dos Santos, RN; Fernandes, DC; Gomes, RDC; Lima, K; Machado-Neto, JA; Rodrigues Junior, MT; Vicari, HP1

Other Studies

1 other study(ies) available for cyclopentane and Leukemia, Promyelocytic, Acute

ArticleYear
Synthetic cyclopenta[b]indoles exhibit antineoplastic activity by targeting microtubule dynamics in acute myeloid leukemia cells.
    European journal of pharmacology, 2021, Mar-05, Volume: 894

    Topics: Antineoplastic Agents; Apoptosis; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cyclopentanes; DNA Damage; Drug Resistance, Neoplasm; Humans; Indoles; Leukemia, Promyelocytic, Acute; Microtubules; Mitosis; Models, Molecular; Stathmin; Tumor Stem Cell Assay

2021